Global Nasal Spray Devices Market Anticipated to Reach USD 6,044.1 Million by 2030

According to a recent market study published by Growth Market Reports, titled, “Global Nasal Spray Devices Market by Dosage Type, by Container Type, by Application, by End User, and by Region: Size, Share, Trends, and Opportunity Analysis, 2019-2030”, the market was valued at USD 3,245.7 Million in 2021 and is expected to grow at a growth rate of 6.9% by the year 2030.

Get Sample Report @ https://growthmarketreports.com/request-sample/5334

Nasal spray devices are containers used to store liquid and semi-solid formulations, which are available in unit/single dose, bi-unit, and multidose devices. The uni-dose and bi-dose nasal spray devices come with portable packages for systemic and local administration, which allow easy and safe delivery of the nasal drug dosage.

These drug-delivery devices are widely used for the topical treatment of local diseases in the nose and paranasal sinuses such as allergic & non-allergic rhinitis and sinusitis. The closed container system used for nasal spray drug products includes pressurized metered and non-pressurized devices. The nasal spray devices are also used for delivering hormone treatments for mental illness through the nose. The nasal spray devices offer several advantages over conventional drug delivery systems, as these devices address issues such as poor bioavailability, slow absorption, drug degradation, adverse events in the gastrointestinal tracts, and avoid the first pass metabolism in the liver.

The Coronavirus 2019 (COVID-19) highlighted economic disparities, global interdependence, and governance challenges. COVID-19 has a moderate impact on the industry, due to the simultaneous reduction of supply and demand. The pandemic caused a slight slowdown in market expansion. The manufacturing of many devices and electronics where postponed.

As per growth market reports industry analyst, “The medical device industry is growing at a fast pace, owing to the rising demand from the healthcare sector and this is expected to contribute to the growth of the Global Nasal Spray Devices Market.”

A supply chain is a network between manufacturers and suppliers to produce and distribute a specific product to the final buyers. This network includes different people, regulatory bodies, entities, information, and resources. Entities in the supply chain include raw material suppliers, manufacturers, logistics, warehouses distributors, and customers. Device distributors are an important part of the supply chain.

Key Takeaways from the Study

• The players in the Global Nasal Spray Devices Market include AptarGroup, Inc.; BD; Air Liquide; Teleflex Incorporated; Recipharm AB; Nemera; RENAISSANCE LAKEWOOD, LLC.; Parekhplast India Limited; KINDEVA DRUG DELIVERY; Gerresheimer; and others.
• Nasal spray devices are largely administered for the treatment of local diseases in a nasal passage. Several manufacturers of nasal spray devices do advertising campaigns to increase awareness about the benefits of the nasal spray devices. Increasing preference of patients towards nasal spray devices, due to the growing awareness of these products and their efficacy and easy to administer properties, is expected to fuel the market. On May 10, 2022, GSK group of companies introduced “Life is a Struggle” campaign, which spread the awareness for the treatment of blocked nose that ultimately increased the sale of nasal spray devices. Rising awareness among patients and physicians about the benefits of nasal spray drugs is expected to drive the market.
• Drugs are delivered into the systemic circulation by various routes, such as oral and parenteral (intramuscular and intravenous). The drug delivered through these routes undergo enzymatic or acidic degradation and register an excessive first-pass effect (hepatic metabolism) after the administration. Sometimes, owing to these reasons, effective drug doses do not reach the systemic circulation, which results in ineffective treatment. The use of a nasal spray device helps in the accurate delivery of the drug with a limited dosage. The nasal spray devices offer several advantages such as poor bioavailability, slow absorption, drug degradation, adverse events in the gastrointestinal tracts, and avoids the first pass metabolism in the liver. Thus, increasing demand for nasal spray devices as an alternative administration route option boosts the market.
• On the basis of dosage type, the global nasal spray devices market is segmented into unit/single dose, bi-dose, and multi-dose. The unit/single dose segment held a market share of XX% in 2021 and is expected to expand at a CAGR of XX% from 2022 to 2030. A unit-dose device is a single-use, pre-filled, pre-assembled, disposable product, such as IMITREX (sumatriptan nasal spray) and NARCAN (naloxone nasal spray). It is an ideal product for urgent treatments, which in turn, is driving the demand for unit/single-dose nasal sprays.
• On the basis of container type, the global nasal spray devices market is bifurcated into non-pressurized containers and pressurized containers. The non-pressurized containers segment held a significant share of XX% in 2021 and is expected to expand at a CAGR of XX% from 2022 to 2030. A non-pressurized container is made for unit dosage or releasing up to several hundred metered sprays of medication composition. These nasal sprays are convenient to use as compared to pressurized containers, which is driving the segment growth.
• On the basis of application, the global nasal spray devices market is segmented nasal congestion, allergic and non-allergic rhinitis, central nervous system disorders, vaccination, and others. The allergic and non-allergic rhinitis segment is expected to expand at a CAGR of XX% from 2022 to 2030 and held a significant share of XX% in 2021. The segment growth is attributed to the wide prevalence of rhinitis globally. Rhinitis, as a common viral infection, affect 10-30% of all adults and up to 40% of children in the US.
• On the basis of end-user, the global nasal spray devices market is segmented into home care settings, hospitals & clinics, pharmaceutical companies, and others. The home care settings segment held a significant share of XX% in 2021 and is expected to expand at a CAGR of XX% from 2022 to 2030. The segment growth is attributed to increasing preference of patients for self-administrated drugs and the availability of user-friendly nasal sprays for home use.
• On the basis of region, the global nasal spray devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for XX% of the market during 2021, due to the growing geriatric population and rising prevalence of allergic & non-allergic rhinitis diseases as well as CNS disorders. Increasing investment in technologically advanced medical devices and nasal sprays for efficient treatment is driving the market in North America.

Report Scope

Target Audience

• Supply-side: Manufacturer and distributors
• Demand Side: Healthcare industry
• Regulatory Side: Concerned government authorities and other approved regulatory bodies
• Associations and Industry Bodies: The Occupational Safety and Health Administration, Food and Drug Administration